Immunogenicity and safety of AZD1222 (ChAdOx1 nCoV-19) against SARS-CoV-2 in Japan: a double-blind, randomized controlled phase 1/2 trial

Autor: Asano, Michiko, Okada, Hiroshi, Itoh, Yohji, Hirata, Hajime, Ishikawa, Kensuke, Yoshida, Erika, Matsui, Akiko, Kelly, Elizabeth J., Shoemaker, Kathryn, Olsson, Urban, Vekemans, Johan
Zdroj: In International Journal of Infectious Diseases January 2022 114:165-174
Databáze: ScienceDirect